|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 7/08 | |
| C07K 16/28 |
| (11) | Patento numeris | 2117571 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07862653.8 |
| Europos patento paraiškos padavimo data | 2007-12-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-11-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/025105 |
| Data | 2007-12-07 |
| (87) | Numeris | WO 2008/073312 |
| Data | 2008-06-19 |
| (30) | Numeris | Data | Šalis |
| 873627 P | 2006-12-08 | US | |
| 930034 P | 2007-05-11 | US |
| (72) |
PARRY, Graham, US
MAZAR, Andrew P., US
|
| (73) |
Monopar Therapeutics Inc.,
5 Revere Drive, Suite 200, Northbrook, IL 60040,
US
|
| (54) | UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR EPITOPE |
| UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR EPITOPE |